{"id":22174,"date":"2026-04-30T23:12:00","date_gmt":"2026-05-01T04:12:00","guid":{"rendered":"https:\/\/magicdichol.info\/kurucunun-kosesi-13-sayi-cift-kor-deneme\/"},"modified":"2026-09-23T10:05:50","modified_gmt":"2026-09-23T15:05:50","slug":"kurucunun-kosesi-13-sayi-cift-kor-deneme","status":"publish","type":"post","link":"https:\/\/magicdichol.info\/tr\/kurucunun-kosesi-13-sayi-cift-kor-deneme\/","title":{"rendered":"Kurucunun K\u00f6\u015fesi 13. Say\u0131: \u00c7ift K\u00f6r Deneme"},"content":{"rendered":"\n

\u00c7ift k\u00f6r deneme, ila\u00e7 \u015firketlerinin yapt\u0131\u011f\u0131 testlerin temelini olu\u015fturur. \u00dcr\u00fcn etkinli\u011fini de\u011ferlendirmek i\u00e7in temel bir y\u00f6ntem olarak kabul g\u00f6rm\u00fc\u015ft\u00fcr. Ancak, ger\u00e7ekten de kendisine atfedilen \u201calt\u0131n standart\u201d niteli\u011findeki g\u00fcvenilirli\u011fi sa\u011fl\u0131yor mu? <\/p>\n

NANO SOMA\u00ae\u2019n\u0131n geli\u015ftiricisi olan ve daha \u00f6nce ila\u00e7 sekt\u00f6r\u00fcnde \u00e7al\u0131\u015fm\u0131\u015f olan Dr. Raghavan, bu \u00fcr\u00fcne b\u00fcy\u00fck ila\u00e7 \u015firketlerinin verdi\u011fi \u00f6nemi vermiyor.<\/p>\n

Bunun nedeni, Nature<\/em> dergisinde yay\u0131mlanan\u201chttps:\/\/nature.thenanosoma.com\/<\/a>\u201d ba\u015fl\u0131kl\u0131 makalede ele al\u0131nmaktad\u0131r.<\/p>\n

Yazar Nicholas Schork, geleneksel klinik \u00e7al\u0131\u015fmalar\u0131n kendileri i\u00e7in iddia edilen sonu\u00e7lar\u0131 sa\u011flamad\u0131\u011f\u0131n\u0131 savunuyor; bunun nedenlerinden biri, halk\u0131n fiziksel profilindeki \u00e7e\u015fitlilik \u2013 genetik ve \u0131rksal de\u011fi\u015fkenler dahil \u2013 iken, bu \u00e7al\u0131\u015fmalar\u0131n genellikle beyazlar gibi ortak bir profile sahip ki\u015filer \u00fczerinde y\u00fcr\u00fct\u00fclme e\u011filiminde olmas\u0131d\u0131r. Sonu\u00e7 olarak, ilac\u0131n yard\u0131mc\u0131 olabilece\u011fi her bir ki\u015fiye kar\u015f\u0131l\u0131k, ilac\u0131n hi\u00e7bir faydas\u0131 olmayan 24 ki\u015fiye kadar \u00e7\u0131kabilmektedir. Bu durum, t\u0131p uzmanlar\u0131n\u0131n bir hastaya en uygun tedaviyi bulmak i\u00e7in genellikle birka\u00e7 tedavi y\u00f6ntemini denemelerinin nedenlerinden biridir. Raghu\u2019nun da dedi\u011fi gibi, kan bas\u0131nc\u0131 ila\u00e7lar\u0131ndan biri ger\u00e7ekten i\u015fe yarasayd\u0131, di\u011ferleri piyasadan silinirdi. <\/p>\n

Bir ba\u015fka se\u00e7enek de N-of-1 denemeleridir ve bunun en basit bi\u00e7imi, ki\u015fisel tan\u0131kl\u0131klard\u0131r \u2013 insanlar\u0131n deneyimlerini ba\u015fkalar\u0131yla payla\u015farak \u00fcr\u00fcn\u00fcn etkinli\u011fini teyit etmeleridir.<\/p>\n

\u0130la\u00e7 end\u00fcstrisi de kabul g\u00f6rm\u00fc\u015f deneme s\u00fcrecinin s\u00fcrd\u00fcr\u00fclmesinde b\u00fcy\u00fck bir \u00e7\u0131kara sahiptir; zira \u00e7ift k\u00f6r deneme s\u00fcrecinin getirdi\u011fi maliyetler, alternatif \u00e7\u00f6z\u00fcmler i\u00e7in ciddi bir giri\u015f engeli te\u015fkil etmektedir. \u0130la\u00e7 end\u00fcstrisinin, Standard Oil ile \u00fcnlenen John D. Rockefeller\u2019\u0131n Almanya\u2019da petrol ar\u0131t\u0131m\u0131n\u0131n bir at\u0131k \u00fcr\u00fcn\u00fc olan katran kumlar\u0131ndan yap\u0131lan ilk ila\u00e7lar\u0131 ke\u015ffetmesiyle ciddi anlamda ba\u015flad\u0131\u011f\u0131n\u0131 pek az ki\u015fi bilir; bu ke\u015fif, onu Bat\u0131 (allopatik) t\u0131bb\u0131n\u0131 bir sat\u0131\u015f g\u00fcc\u00fc olarak yaratmaya y\u00f6neltmi\u015ftir. \u0130nsanl\u0131k do\u011fal \u015fifa y\u00f6ntemlerinden insan yap\u0131m\u0131 kimyasallara y\u00f6neldik\u00e7e, \u00e7ift k\u00f6r deneme de end\u00fcstri ile birlikte ortaya \u00e7\u0131km\u0131\u015ft\u0131r. <\/p>\n

Bana g\u00f6re, t\u0131pk\u0131 tar\u0131mda oldu\u011fu gibi, do\u011fal \u00e7\u00f6z\u00fcmlere geri d\u00f6nd\u00fck\u00e7e, do\u011fal olmayan ila\u00e7larla olan ili\u015fkimizin de ge\u00e7ici bir a\u015fama oldu\u011fu ortaya \u00e7\u0131kacakt\u0131r.<\/p>\n\n\t

\n\t\t
\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t
\n\t\t\t\n\n
\n\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n\n\t
\n\t\t\n\n

Bunun size ne gibi faydalar sa\u011flayabilece\u011fini g\u00f6rmeye haz\u0131r m\u0131s\u0131n\u0131z?<\/p>\n

A\u015fa\u011f\u0131daki d\u00fc\u011fmeye dokunun ve bunu nas\u0131l yapabilece\u011finizi \u00f6\u011frenin!<\/p>\n\t\t\n